Logix Biosciences
Manifesto § 01 Logix Biosciences
§ 01 · The manifesto 2026 edition

Thinking
beyond
corticosteroids.

A Nasal Revolution · 2023–

Opportunistic nasal bacteria, microscopy simulation

§ Opening

"Welcome to the groundbreaking field of Nasal Immune Modulation. This isn't just symptom treatment — it is a revolution in health."

From the 2023 clinical brief

§ 02

A breakthrough
immune modulator.

Unveiling a non-steroidal immune modulator that clears infections, viral and bacterial intruders, allergens, and biofilm — by enhancing the body's natural defenses, not suppressing them.

  1. Clearing the nasal cavity

    A non-drug pathway that addresses allergens, particulate, viral and bacterial intruders, and biofilm at the respiratory gateway.

  2. Modulating, not suppressing

    Corticosteroids act as immunosuppressants. We take the opposite approach: tune the innate response to let the body do its work.

  3. Proven constituents

    Built on ingredients with peer-reviewed compatibility with the nasal immune ecosystem. If the system is impaired, the formulation may help kick-start repair.

  4. Clinically oriented

    Built for ENT specialists and family doctors who already see the limits of antibiotics-first and steroids-first playbooks.

§ 03 · Our position

Defeating
infections,
allergens,
biofilm.

— without steroids.

Most protocols for colds, flu, allergies, and sinusitis default to two tools: antibiotics and corticosteroids. Both have their place. Neither is the right first line for the overwhelmingly viral reality of upper respiratory disease.

We believe the nasal cavity is a living ecosystem — not a surface to sterilize. Nasal Immune Modulation treats it that way.

§ 04 · Inside the ecosystem

The nasal immune ecosystem is not a surface. It is a community.

Billions of commensal organisms line the nasal cavity and compete against opportunistic pathogens. Our research focuses on how to support that community rather than clear-cut it.

Commensal and opportunistic bacteria in the nasal cavity
Staphylococcus, commensal bacteria

§ 05 · For physicians

A first-line protocol
for rhinosinusitis
without defaulting to steroids.